What is Vivani?
Vivani Medical, Inc., established in 2010 and based in California, is dedicated to creating advanced implantable solutions for chronic diseases. The company operates within the clinical stage, signifying its transition from research and development to the crucial phases of clinical trials and regulatory approval. Its focus on conditions with high unmet medical needs positions it in a critical segment of the healthcare innovation landscape, aiming to provide novel therapeutic options where current treatments are insufficient.
How much funding has Vivani raised?
Vivani has raised a total of $122.3M across 5 funding rounds:
Stock Offering
$31.5M
Stock Offering
$57.5M
Other Financing Round
$15M
Share Placement
$8.3M
Other Financing Round
$10M
Stock Issuance/Offering (2014): $31.5M, investors not publicly disclosed
Stock Issuance/Offering (2021): $57.5M, investors not publicly disclosed
Other Financing Round (2024): $15M, investors not publicly disclosed
Share Placement (2025): $8.3M, investors not publicly disclosed
Other Financing Round (2025): $10M, investors not publicly disclosed
What's next for Vivani?
The substantial enterprise-level funding Vivani has attracted indicates a strong investor confidence in its technology and market potential. This capital infusion is likely earmarked for advancing its clinical trial pipeline, scaling manufacturing capabilities, and potentially pursuing regulatory submissions. The company's strategic direction will be pivotal in translating its innovative implant technology into commercially viable treatments, thereby solidifying its position in the competitive medical device sector.
See full Vivani company page
